Skip to main content
logo
Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
59.35
+0.89 (1.53%)
At close: Sep 8, 2026, 4:00 PM EDT
59.87
+1.42 (2.43%)
Pre-market: Sep 9, 2026, 8:52 AM EDT

Eton Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
105.679.9539.0131.6421.2521.83
Revenue Growth
81.49%104.94%23.29%48.90%-2.66%55879.49%
Gross Profit
64.8547.8323.4121.0614.3219.01
Operating Income
20.644.83-2.18-1.19-8.26-1.5
Net Income
12.69-4.6-3.82-0.94-9.02-1.96
Earnings Per Share
0.43-0.17-0.15-0.04-0.36-0.08
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
26.8525.9414.9421.3916.3114.41
Total Debt
29.2331.0829.995.466.526.7
Net Cash (Debt)
-2.38-5.14-15.0615.939.787.71
Net Cash Growth
---62.90%26.85%-45.52%
Net Cash Per Share
-0.08-0.19-0.580.620.390.31

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
15.1410.520.976.824.82-4.72
Capital Expenditures
-0.4-0.33-0.03--0.04-0.01
Free Cash Flow
14.7310.190.946.824.78-4.73
Free Cash Flow Growth
20.52%980.70%-86.16%42.48%--

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
61.41%59.83%60.01%66.56%67.38%87.05%
Operating Margin
19.54%6.04%-5.59%-3.77%-38.87%-6.85%
Pretax Margin
12.08%-5.70%-9.76%-2.18%-42.45%-8.95%
Profit Margin
12.02%-5.75%-9.80%-2.96%-42.45%-8.96%
FCF Margin
13.95%12.75%2.42%21.54%22.51%-21.66%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
39.9030.5657.9179.6432.859.98
P/FCF Ratio
115.1444.50376.2216.4914.92-
PS Ratio
16.065.679.093.553.364.84